✦ LIBER ✦

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics

✍ Scribed by E. H. Lips; L. Mulder; J. J. de Ronde; I. A. M. Mandjes; A. Vincent; M. T. F. D. Vrancken Peeters; P. M. Nederlof; J. Wesseling; S. Rodenhuis

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 392 KB
Volume: 131
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1488-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical expression of HER1,

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

✍ Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Akihiro Hirakawa; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

The predictive value of PgR and HER-2 fo

The predictive value of PgR and HER-2 for response to primary systemic chemotherapy in inflammatory breast cancer

✍ Hiroko Nogi; Tadashi Kobayashi; Isao Tabei; Kazumi Kawase; Yasuo Toriumi; Masafu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 256 KB

Association between HER2, TOP2A, and res

Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer

✍ Gottfried E. Konecny; Giovanni Pauletti; Michael Untch; He-Jing Wang; Volker Möb 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 401 KB

Comparison of different approaches for a

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)

✍ A. Noske; S. Loibl; S. Darb-Esfahani; M. Roller; R. Kronenwett; B. M. Müller; J. 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 287 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views